Description |
Verminoside is an iridoid isolated from Kigelia africana, exhibits anti-inflammatory and remarkable antioxidant activity with a radical-scavenging activity of 2.5 μg/mL. The genotoxicity of Verminoside on human lymphocytes is associated with elevated levels of PARP-1 and p53 proteins[1][2][3].
|
Target |
PARP-1
|
In Vitro |
Verminoside (Compound 1; 0.01-1 mM; 25 hours; J774.A1 macrophages) treatment shows significant and concentration-related inhibition of iNOS expression at 0.1 mM and 1 mM in LPS-stimulated J774.A1 macrophages[1]. Western Blot Analysis[1] Cell Line: J774.A1 macrophages Concentration: 0.01 mM, 0.1 mM or 1 mM Incubation Time: 25 hours Result: Showed significant and concentration-related inhibition of iNOS expression at 0.1 mM and 1 mM in LPS-stimulated J774.A1 macrophages.
|
Density | 1.6±0.1 g/cm3 |
Boiling Point | 739.1±60.0 °C at 760 mmHg |
Flash Point | 253.2±26.4 °C |
Exact Mass | 492.163147 |
PSA | 208.13000 |
LogP | -1.81 |
Vapour Pressure | 0.0±2.6 mmHg at 25°C |